Concepedia

W. Mark Abbott

WM

Statistics

Publications

17

Citations

681

H-Index

14

Active since

1985

Affiliations

AstraZeneca (United Kingdom)(Current)

AstraZeneca (Sweden)

University of Manchester

Queen's Medical Centre

W. Mark Abbott is an author at AstraZeneca (United Kingdom) specializing in life sciences, biochemistry, and molecular biology.

Publications per year

1985–2021

17

Publications

17

Crystal Structures of Human ADAMTS-1 Reveal a Conserved Catalytic Domain and a Disintegrin-like Domain with a Fold Homologous to Cysteine-Rich Domains

S. Gerhardt, G. Hassall, Paul Hawtin et al. · Journal of Molecular Biology · 2007 · 97 citations

, , +8

Biochemical characterization and deletion analysis of recombinant human protein phosphatase 2Cα

Anna E. Marley, Jane E. Sullivan, David Carling et al. · Biochemical Journal · 1996 · 87 citations · Full text

, , +16

Structure of IL-17A in Complex with a Potent, Fully Human Neutralizing Antibody

S. Gerhardt, W. Mark Abbott, David Hargreaves et al. · Journal of Molecular Biology · 2009 · 81 citations

, , +9

Cellularly active N-hydroxyurea FEN1 inhibitors block substrate entry to the active site

Jack Exell, Mark J. Thompson, L. David Finger et al. · Nature Chemical Biology · 2016 · 77 citations · Full text

, , +5

Heparan sulfates are critical regulators of the inhibitory megakaryocyte-platelet receptor G6b-B

Timo Vögtle, Sumana Sharma, Jun Mori et al. · eLife · 2019 · 64 citations · Full text

, , +17

1–5 of 17